A CANCER patient in Cornwall has praised the work being done by an NHS research team in the county which has given her new hope.

Emma Hunkin, 47, from Penwithick, near St Austell, has been living with myeloma, a type of blood cancer, since being diagnosed with the disease in December 2022.

Emma, who works at a coffee shop, was offered the opportunity to take part in research and join a Royal Cornwall Hospitals NHS Trust clinical trial shortly after her diagnosis.

The trial, which involves induction chemotherapy, a stem cell transplant, consolidation treatment and ongoing maintenance treatment, has significantly improved Emma’s quality of life.

Emma’s husband, Neil, and their son, Will, have been a constant source of support. The family, who enjoy exploring the Cornish coast together, are grateful for the help from the research team, especially during the few occasions when Emma has been unwell.

Emma said: “The support from the research team has been incredible. I feel lucky to have been given the opportunity to be treated through a clinical trial that has put me in a solid remission and keeps me there.”

Emma’s treatment plan includes fortnightly hospital visits for infusions and monthly appointments for reviews. Despite some side-effects that impact her energy levels, Emma continues to work, exercise and travel, living as well with the treatment as she did before her diagnosis.

An NHS trust spokesperson said: “Emma’s story is a testament to the importance and power of research in finding effective treatments for incurable diseases like myeloma. Her journey offers hope and inspiration to others facing similar challenges.

“The trial is looking at treatments to improve outcomes for patients with myeloma. We have been running this trial since 2022. The haematology research team is a team of five who work very closely with the haematology consultants and specialist staff to deliver research.”